Advertisement

Infantile Hemangiomas

  • Tor Shwayder
  • Samantha L. Schneider
  • Devika Icecreamwala
  • Marla N. Jahnke
Chapter
  • 209 Downloads

Abstract

Infantile hemangiomas (IH) represent the most common soft tissue tumor of infancy. These neoplasms are more common in females (2–5:1) and affect 4–5% of infants [1]. Risk factors for the development of IH include premature or low-birth weight infants, mothers who underwent chorionic villus sampling, or multiple gestation infants [1].

References

  1. 1.
    Bolognia J, Jorizzo J, Schaffer J. Dermatology. 3rd ed. Elsevier; 2012.Google Scholar
  2. 2.
    Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: a systematic review. Lasers Surg Med. 2016;48(3):221–33.CrossRefGoogle Scholar
  3. 3.
    Janmohamed SR, van Oosterhout M, de Laat PC, van Rosmalen J, Madern GC, Oranje AP. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: a prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS). J Am Acad Dermatol. 2015;73(2):258–263. Jahnke MN. Vascular Lesions. Pediatr Ann. 2016;45(8):e299–305.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Tor Shwayder
    • 1
  • Samantha L. Schneider
    • 2
  • Devika Icecreamwala
    • 3
  • Marla N. Jahnke
    • 2
  1. 1.Pediatric DermatologyHenry Ford HospitalDetroitUSA
  2. 2.Department of DermatologyHenry Ford HospitalDetroitUSA
  3. 3.Icecreamwala DermatologyBerkeleyUSA

Personalised recommendations